Senti Biosciences Q4 2023 GAAP EPS $(0.42) Misses $(0.28) Estimate
Portfolio Pulse from Benzinga Newsdesk
Senti Biosciences reported a Q4 2023 GAAP EPS loss of $(0.42), missing the consensus estimate of $(0.28) by 50%.
March 21, 2024 | 8:11 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Senti Biosciences reported a larger than expected loss in Q4 2023, missing analyst estimates.
Missing earnings estimates, especially by a significant margin such as 50%, typically leads to negative investor sentiment and can result in a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100